Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Neogen Chemicals is an Indian specialty chemicals manufacturer focused on bromine‑based compounds, lithium salts, grignard reagents and CDMO/contract manufacturing, operating facilities at Mahape and Karakhadi while expanding operations at Dahej SEZ and via Neogen Ionics to address battery‑grade electrolyte and salt markets.
The company has pivoted decisively into battery materials via an 80/20 JV with Japan’s Morita, Pakhajan greenfield development and Dahej scale‑up to produce LiPF6 salts and formulated electrolytes, positioning Neogen as a non‑FEOC alternative to Chinese supply and benefiting from US 45X and India localization tailwinds.
Q3 FY26 delivered consolidated revenue of INR 220 crore (9% YoY) with gross profit up 13% and ~150 basis points margin expansion; EBITDA was INR 32 crore and PAT INR 4 crore, with near‑term margin pressure from Neogen Ionics ramp, fire‑related rebuilding costs, interim tolling expenses and higher finance costs despite insurance receipts totaling INR 83.48 crore to date.
Management is executing multiple financing flows: an in‑principle INR 150 crore promoter preferential allotment, expected $20 million Morita equity infusion for the JV, and anticipated insurance settlements (net receivable ~INR 251.12 crore) to collectively shore up liquidity and support capex and working capital for battery vertical scale‑up.
Operationally, Dahej replacement plant commissioning is on track for Q1 FY27, Neogen Ionics contributed INR 12 crore in Q3, Pakhajan trials and equipment assembly are underway with commercial electrolyte targeted H1 FY27 and salt targeted H2 FY27, and management is maintaining FY27 battery chemicals guidance of INR 400–500 crore.
Chemicals & Petrochemicals
Specialty Chemicals
4,125 Cr
Moderate Risk
200.2
42.1
1.4
4.3
1,788.00
978.00
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
3
Bullish
36
Bearish
0
Neutral
0
Bullish
32
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
894.20 | 5,045 Cr | 11.42 | 2.40 | 0.51 | 19.15 | 19.53 | 10.44 | ||
1497.20 | 4,125 Cr | 200.16 | 4.29 | 0.06 | 4.11 | 5.72 | 0.86 | ||
503.70 | 4,054 Cr | 24.56 | 4.05 | 0.05 | 13.84 | 15.78 | 7.54 | ||
2172.45 | 3,946 Cr | 22.82 | 3.17 | 1.38 | 16.09 | 14.97 | 7.37 | ||
117.90 | 3,903 Cr | 41.09 | 2.02 | 0.35 | 4.33 | 4.87 | 2.49 | ||
1041.30 | 3,902 Cr | 23.53 | 2.07 | 0.91 | 7.75 | 10.38 | 6.21 | ||
4607.40 | 3,505 Cr | 45.46 | 3.38 | 0.54 | 8.43 | 12.26 | — | ||
| Median: 7 Co. | — | 1041.30 | 3,946 Cr | 24.56 | 3.17 | 0.51 | 8.43 | 12.26 | 6.79 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Neogen Chemicals Ltd (NEOGEN) is currently trading at 1,664.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Neogen Chemicals is an Indian specialty chemicals manufacturer focused on bromine‑based compounds, lithium salts, grignard reagents and CDMO/contract manufacturing, operating facilities at Mahape and Karakhadi while expanding operations at Dahej SEZ and via Neogen Ionics to address battery‑grade electrolyte and salt markets. The company has pivoted decisively into battery materials via an 80/20 JV with Japan’s Morita, Pakhajan greenfield development and Dahej scale‑up to produce LiPF6 salts and formulated electrolytes, positioning Neogen as a non‑FEOC alternative to Chinese supply and benefiting from US 45X and India localization tailwinds. Q3 FY26 delivered consolidated revenue of INR 220 crore (9% YoY) with gross profit up 13% and ~150 basis points margin expansion; EBITDA was INR 32 crore and PAT INR 4 crore, with near‑term margin pressure from Neogen Ionics ramp, fire‑related rebuilding costs, interim tolling expenses and higher finance costs despite insurance receipts totaling INR 83.48 crore to date. Management is executing multiple financing flows: an in‑principle INR 150 crore promoter preferential allotment, expected $20 million Morita equity infusion for the JV, and anticipated insurance settlements (net receivable ~INR 251.12 crore) to collectively shore up liquidity and support capex and working capital for battery vertical scale‑up. Operationally, Dahej replacement plant commissioning is on track for Q1 FY27, Neogen Ionics contributed INR 12 crore in Q3, Pakhajan trials and equipment assembly are underway with commercial electrolyte targeted H1 FY27 and salt targeted H2 FY27, and management is maintaining FY27 battery chemicals guidance of INR 400–500 crore.
Over the past 52 weeks, Neogen Chemicals Ltd has traded between a low of ₹978.00 and a high of ₹1,788.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Neogen Chemicals Ltd has a market capitalization of approximately 4,125.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Neogen Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 200.16 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4,125.19 Cr, Neogen Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Neogen Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Neogen Chemicals Ltd is 200.16. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Preferential allotment
Cadamba Solutions Pvt Ltd was allotted 1,000,000 equity shares of Neogen Chemicals at Rs.1,610 each (aggregate Rs.161 crore) on Apr 18, 2026 via preferential allotment, representing 3.79% pre- and 3.65% post-allotment; acquirer is part of promoter group.
Preferential Allotment
Cadamba Solutions Pvt Ltd (a promoter-group entity) was allotted 1,000,000 equity shares of Neogen Chemicals Ltd at Rs 1,610/share via preferential allotment on Apr 18, 2026 (Rs 161 crore), representing 3.79% pre- and 3.65% post‑allotment stake.
Preferential allotment
Cadamba Solutions Pvt Ltd (promoter group) subscribed to 1,000,000 equity shares of Neogen Chemicals on April 18, 2026 via preferential allotment at Rs.1,610/share (total Rs.161 crore), representing ~3.65% post‑allotment stake.
Preferential Allotment
Cadamba Solutions Pvt Ltd (promoter group) subscribed to 1,000,000 Neogen Chemicals equity shares at Rs.1,610 each via preferential allotment on April 18, 2026, for Rs.161 crore, ~3.65% post‑allotment stake.
Preferential allotment
Cadamba Solutions (promoter group) was allotted 1,000,000 equity shares of Neogen Chemicals on April 18, 2026 at Rs.1,610/share (aggregate Rs.161 crore) via preferential allotment, taking its holding to ~3.65% post‑allotment.
Preferential allotment
Cadamba Solutions (promoter group) acquired 1,000,000 Neogen Chemicals shares via preferential allotment on Apr 18, 2026 at Rs.1,610/share (aggregate Rs.161 crore), representing 3.79% pre- and 3.65% post-allotment stake.
